Browse by all authors Browse By Author Name - Nash,+Peter

Browse Results (52 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 2

Result Pages:    1 2  next › last »

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Smolen, Josef S., Freundlich, Bruce, Pavelka, Karel, Nash, Peter, Miranda, Pedro, Hammond, Constance, Vlahos, Bonnie, Pedersen, Ronald and Koenig, Andrew S. (2011). Achievement of low disease activity or remission with etanercept-methotrexate therapy in subjects with moderately active rheumatoid arthritis: preliminary results from the preserve trial. In: Supplement to Rheumatology: Excellence in Rheumatology Abstracts. Conference on Excellence in Rheumatology, Istanbul, Turkey, (ii12-ii12). 17-19 February 2011. doi:10.1093/rheumatology/ker097 546   0 Cited 0 times in Scopus0 0
Kowal-Bielecka, Otylia, Avouac, Jerome, Pittrow, David, Huscher, Doerte, Behrens, Frank, Denton, Christopher P., Foeldvari, Ivan, Humbert, Marc, Matucci-Cerinic, Marco, Nash, Peter, Opitz, Christian F., Rubin, Lewis J., Seibold, James R., Strand, Vibeke, Furst, Daniel E. and Distler, Oliver (2011) Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: Results of a systematic literature analysis by the expert panel on outcomes measures in pulmonary arterial hypertension related to systemic sclerosis (EPOSS). Journal of Rheumatology, 38 11: 2419-2427. doi:10.3899/jrheum.110344 127   0 Cited 0 times in Scopus0 0
Zochling, Jane, Newell, Felicity, Charlesworth, Jac C., Leo, Paul, Stankovich, Jim, Cortes, Adrian, Zhou, Yuan, Stevens, Wendy, Sahhar, Joanne, Roddy, Janet, Nash, Peter, Tymms, Kathleen, Rischmueller, Maureen, Lester, Sue, Proudman, Susanna and Brown, Matthew A. (2014) An immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3. Arthritis Research & Therapy, 16 5: 1-7. doi:10.1186/s13075-014-0438-8 50   0 0
Nash, Peter (2009) Assessment and treatment of psoriatic spondylitis. Current Rheumatology Reports, 11 4: 278-283. doi:10.1007/s11926-009-0039-8 15   Cited 4 times in Scopus4 0
Nash, Peter and Nicholls, Dave (2012). A survey study of methotrexate use by rheumatologists and their patients with rheumatoid arthritis. In: Abstracts of the American College of Rheumatology & Association of Rheumatology Health Professionals, Annual Scientific Meeting. Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, DC, United States, (S670-S670). 9-14 November 2012. doi:10.1002/art.37735 44   0 0
Gladman, Dafna D, Mease, Philip J, Strand, Vibeke, Healy, Paul, Helliwell, Philip S, Fitzgerald, Oliver, Gottlieb, Alice B, Krueger, Gerald G., Nash, Peter, Ritchlin, Christopher T, Taylor, William, Adebajo, Ade, Braun, Jurgen, Caull, Alberto, Carneiro, Sueli, Choy, Ernst, Dijkmans, Ben, Espinoza, Luiz, van der Heijde, Desiree, Husni, Elaine, Lubrano, Ennio, McGonagle, Dennis, Qureshi, Abrar, Soriano, Enrique R and Zochling, Jane (2007) Consensus on a core set of domains for psoriatic arthritis. Journal of Rheumatology, 34 5: 1167-1170. 95   97 Cited 104 times in Scopus104
Distler, Oliver, Behrens, Frank, Pittrow, David, Huscher, Doerte, Denton, Christopher P., Foeldvari, Ivan, Humbert, Marc, Matucci-Cerinic, Marco, Nash, Peter, Opitz, Christian F., Rubin, Lewis J., Seibold, James R., Furst, Daniel E. and EPOSS-Omeract Group (2008) Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: A Delphi consensus study with cluster analysis. Arthritis Care and Research, 59 6: 867-875. doi:10.1002/art.23718 72   25 Cited 26 times in Scopus26 0
Taylor, William J., Korendowych, Eleanor, Nash, Peter, Helliwell, Philip S., Choy, Ernest, Krueger, Gerald G., Soriano, Enrique R., Mchugh, Neil J. and Rosen, Cheryl F. (2008) Drug use and toxicity in psoriatic disease: Focus on methotrexate. Journal of Rheumatology, 35 7: 1454-1457. 42   19 Cited 22 times in Scopus22
Nash, Peter T., Ludivico, Charles L., Delaet, Ingrid, Qi, Kiqin, Murthy, Bindu, Corbo, Michael and Kaine, Jeffrey L. (2011). Efficacy, safety and pharmacokinetics of subcutaneous abatacept in patients with rheumatoid arthritis, with or without an intravenous (IV) loading dose. In: Abstracts of the American College of Rheumatology and Association of Rheumatology Health Professionals Annual Scientific Meeting. 75th Annual Scientific Meeting of the American College of Rheumatology/46th Annual Scientific Meeting of the Association of Rheumatology Health Professionals, Chicago, IL, United States, (S151-S151). 4-9 November 2011. doi:10.1002/art.33310 101   2 0
Nash, Peter T., Ludivico, Charles L., Delaet, Ingrid, Qi, Keqin, Murthy, Bindu, Corbo, Michael and Kaine, Jeffrey L. (2012). Efficacy, safety and pharmacokinetics of subcutaneous abatacept in patients with rheumatoid arthritis, with or without an intravenous loading dose. In: Rheumatology 2012 Abstracts. Annual Meeting of the British-Society-for-Rheumatology, Glasgow Scotland, (iii133-iii134). May 1-3 2012. 40   0
Moore, Owen A., Goh, Nicole, Corte, Tamera, Rouse, Hannah, Hennessy, Oliver, Thakkar, Vivek, Byron, Jillian, Sahhar, Joanne, Roddy, Janet, Gabbay, Eli, Youssef, Peter, Nash, Peter, Zochling, Jane, Proudman, Susanna M., Stevens, Wendy and Nikpour, Mandana (2013) Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology, 52 1: 155-160. doi:10.1093/rheumatology/kes289 49   22 Cited 20 times in Scopus20 0
Emery, Paul, Fleischmann, Roy M., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric, Churchill, Melvin A., Park, Won, Pons-Estel, Bernardo, Han, Chenglong, Gathany, Timothy A., Zhou, Yiying, Xu, Stephen and Hsia, Elizabeth C. (2013). Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized, Placebo-Controlled Trial Of Golimumab In Methotrexate-naive Patients With Rheumatoid Arthritis. In: Special Issue: 2013 Annual Meeting Abstract Supplement. 77th Annual Meeting of the American College of Rheumatology / 48th Annual Meeting of the Association of Rheumatology Health Professionals, San Diego Ca, (S188-S189). 25-30 October 2013. 56   0
Emery, Paul, Fleischmann, Roy M., Doyle, Mittie K., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric, Churchill, Melvin, Park, Won, Pons-Estel, Bernardo, Xu, Weichun, Xu, Stephen, Wu, Zhong and Hsia, Elizabeth C. (2013) Golimumab, a Human Anti-Tumor Necrosis Factor Monoclonal Antibody, Injected Subcutaneously Every 4 Weeks in Patients With Active Rheumatoid Arthritis Who Had Never Taken Methotrexate: 1-Year and 2-Year Clinical, Radiologic, and Physical Function Findings of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Arthritis Care and Research, 65 11: 1732-1742. doi:10.1002/acr.22072 26   1 Cited 2 times in Scopus2 0
Emery, Paul, Fleischmann, Roy M., Moreland, Larry W., Hsia, Elizabeth C., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric Jason B., Churchill, Melvin, Park, Won, Pons-Estel, Bernardo Antonio, Doyle, Mittie K., Visvanathan, Sudha, Xu, Weichun and Rahman, Mahboob U. (2009) Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis. Arthritis and Rheumatism, 60 8: 2272-2283. doi:10.1002/art.24638 186   152 Cited 182 times in Scopus182 8
Kay, Jonathan, Matteson, Eric L., Dasgupta, Bhaskar, Nash, Peter, Durez, Patrick, Hall, Stephen, Hsia, Elizabeth C., Han, John, Wagner, Carrie, Xu, Zhenhua, Visvanathan, Sudha and Rahman, Mahboob U. (2008) Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Arthritis and Rheumatism, 58 4: 964-975. doi:10.1002/art.23383 108   137 Cited 172 times in Scopus172 0
Nash, Peter, Nayiager, Sauithree, Genovese, Mark C., Kivitz, Alan J., Oelke, Kurt, Ludivico, Charles, Palmer, William, Rodriguez, Cristian, Delaet, Ingrid, Elegbe, Ayanbola and Corbo, Michael (2013) Immunogenicity, safety, and efficacy of abatacept administered subcutaneously with or without background methotrexate in patients with rheumatoid arthritis: results from a phase III, international, multicenter, parallel-arm, open-label studyy. Arthritis Care and Research, 65 5: 718-728. doi:10.1002/acr.21876 30   17 Cited 15 times in Scopus15 1
Seeman, Ego, Kotowicz, Mark A., Nash, Peter T. and Sambrook, Philip N. (2009) Inappropriate prescribing for osteoporosis. Medical Journal of Australia, 191 6: 355-355. 28   3 Cited 3 times in Scopus3
Nash, Peter, Thaci, Diamant, Behrens, Frank, Falk, Franziska and Kaltwasser, J. Peter (2006) Leflunomide improves psoriasis in patients with psoriatic arthritis: An in-depth analysis of data from the TOPAS study. Dermatology, 212 3: 238-249. doi:10.1159/000091251 99   25 Cited 28 times in Scopus28 0
Alten, Rieke, Kaine, Jeffrey, Keystone, Edward, Nash, Peter, Delaet, Ingrid and Genovese, Mark C. (2014) Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data representing more than four years of treatment. Arthritis and Rheumatology, 66 8: 1987-1997. doi:10.1002/art.38687 17   3 Cited 3 times in Scopus3 2
Smolen, Josef S., Nash, Peter, Durez, Patrick, Hall, Stephen, Ilivanova, Elena, Irazoque-Palazuelos, Fedra, Miranda, Pedro, Park, Min-Chan, Pavelka, Karel, Pedersen, Ronald, Szumski, Annette, Hammond, Constance, Koenig, Andrew S. and Vlahos, Bonnie (2013) Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial. Lancet, 381 9870: 918-929. doi:10.1016/S0140-6736(12)61811-X 28   38 Cited 40 times in Scopus40 25
Khanna, Dinesh, Distler, Oliver, Avouac, Jerome, Behrens, Frank, Clements, Philip J., Denton, Christopher, Foeldvari, Ivan, Giannini, Edward, Huscher, Doerte, Kowal-Bielecka, Otylia, Lovell, Daniel, Matucci-Cerinic, Marco, Mayes, Maureen, Merkel, Peter A., Nash, Peter, Opitz, Christian F., Pittrow, David, Rubin, Lewis, Seibold, James R., Steen, Virginia, Strand, C. Vibeke, Tugwell, Peter S., Varga, John, Zink, Angela and Furst, Daniel E. (2009). Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and outcome measures in pulmonary arterial hypertension related to systemic sclerosis (EPOSS). In: Proceedings of OMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology. OMERACT 9: 9th International Consensus Conference on Outcome Measures in Rheumatology Clinical Trails, Kananaskis Village, AB, Canada, (2356-2361). 27-31 May, 2008. doi:10.3899/jrheum.090372 11   11 Cited 11 times in Scopus11 0
Thakkar, Vivek, Stevens, Wendy M., Prior, David, Moore, Owen A., Byron, Jillian, Liew, Danny, Patterson, Karen, Hissaria, Pravin, Roddy, Janet, Zochling, Jane, Sahhar, Joanne, Nash, Peter, Tymms, Kathleen, Celermajer, David, Gabbay, Eli, Youssef, Peter, Proudman, Susanna M. and Nikpour, Mandana (2012) N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research & Therapy, 14 3: R143-1-R143-10. doi:10.1186/ar3876 51 2 11 Cited 14 times in Scopus14 2
Gladman, Dafna D., Mease, Philip J., Healy, Paul, Helliwell, Philip S., Fitzgerald, Oliver, Cauli, Alberto, Lubrano, Ennio, Krueger, Gerald G., van der Heijde, Désirée, Veale, Douglas J., Kavanaugh, Arthur, Nash, Peter, Rtchlin, Christopher, Taylor, William and Strand, Vibeke (2007) Outcome measures in psoriatic arthritis. Journal of Rheumatology, 34 5: 1159-1166. 90   45 Cited 57 times in Scopus57
Nash, Peter and Nicholls, Dave (2013) Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: AN Australian survey study. International Journal of Rheumatic Diseases, 16 6: 652-661. doi:10.1111/1756-185X.12183 19   0 Cited 0 times in Scopus0 0
Ewald, Dan P., Eisman, John A., Ewald, Ben D., Winzenberg, Tania M., Seibel, Markus J., Ebeling, Peter R., Flicker, Leon A. and Nash, Peter T. (2009) Population rates of bone densitometry use in Australia, 2001-2005, by sex and rural versus urban location. Medical Journal of Australia, 190 3: 126-128. 25   15 Cited 15 times in Scopus15
Nikpour, Mandana, Hissaria, Pravin, Byron, Jillian, Sahhar, Joanne, Micallef, Maree, Paspaliaris, William, Roddy, Janet, Nash, Peter, Sturgess, Alan, Proudman, Susanna and Stevens, Wendy (2011) Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort. Arthritis Research and Therapy, 13 6: R211.1-R211.13. doi:10.1186/ar3544 22   19 Cited 18 times in Scopus18 2
Sambrook, Philip N., Kotowicz, Mark, Nash, Peter, Styles, Colin B., Naganathan, Vasi, Henderson-Briffa, Kathy N., Eisman, John A. and Nicholson, Geoff C. (2003) Prevention and treatment of glucocorticoid-induced osteoporosis: A comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. Journal of Bone and Mineral Research, 18 5: 919-924. doi:10.1359/jbmr.2003.18.5.919 44   70 Cited 93 times in Scopus93 0
Keystone, Edward, Genovese, Mark, Hochberg, Marc, Cohen, Roger, Weinblatt, Michael, Kaine, Jeffrey, Nash, Peter, Delaet, Ingrid and Alien, Rieke (2013). Prolonged Exposure to Subcutaneous and Intravenous Abatacept in Patients with Rheumatoid Arthritis does not Affect Rates of Infection, Malignancy and Autoimmune Events: Results from Pooled Clinical Trial Data. In: Journal of Rheumatology. Canadian-Rheumatology-Association Meeting, Ottawa Canada, (995-995). Feb 13-16, 2013. 16   0
Feletar, Marie and Nash, Peter T. (2010) Psoriatic arthritis: A clinical diagnosis. Medicine Today, 11 11: 69-72. 18   Cited 0 times in Scopus0
Galluccio, Felice, Walker, Ulrich A., Nihtyanova, Svetlana, Moinzadeh, Pia, Hunzelmann, Nicholas, Krieg, Thomas, Steen, Virginia, Baron, Murray, Sampaio-Barros, Percival, Kayser, Cristiane, Nash, Peter, Denton, Chris P., Tyndall, Alan, Muller-Ladner, Ulf and Matucci-Cerinic, Marco (2011) Registries in systemic sclerosis: A worldwide experience. Rheumatology, 50 1: 60-68. doi:10.1093/rheumatology/keq355 46   7 Cited 9 times in Scopus9 0
Standfield, Lachlan, Norris, Sarah, Harvey, Charles, Elliot, Lisa, Riordan, John, Hall, Stephen, Day, Richard, Nash, Peter, Thirunavukkarasu, Krishan, Robertson, James and Palmer, Trish (2010) Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in australian patients: A cross-sectional, multicenter study. Clinical Therapeutics, 32 7: 1329-1342. doi:10.1016/j.clinthera.2010.07.006 50   4 Cited 5 times in Scopus5 0
Al Saleh, Jamal, Ragab, Gaafar, Nash, Peter, Halabi, Hussein, Laatar, Ahmed, El-Sayed Yousef, Ali M., Ehsouna, Hamdi and Hammoudeh, Mohammed (2015) Rheumatoid arthritis in the Middle East and Africa: are we any closer to optimising its management?. Clinical Rheumatology, 34 1: 1-8. doi:10.1007/s10067-014-2818-5 16   0 Cited 0 times in Scopus0 0
Alten, Rieke, Kaine, Jeffrey L., Keystone, Edward, Nash, Peter T., Delaet, Ingrid, Qi, Keqin and Genovese, Mark C. (2012). Safety profile of subcutaneous abatacept focusing On clinically relevant events in patients with rheumatoid arthritis and up to 4.5 years of exposure. In: Rheumatology 2012 Abstracts: Poster Viewing II. Annual Meeting of the British-Society-for-Rheumatology, Glasgow, Scotland, (127-128). 1 - 3 May 2012. doi:10.1093/rheumatology/kes109 34   0 1
Alten, Rieke, Kaine, Jeffrey L., Keystone, Edward, Nash, Peter T., Delaet, Ingrid, Qi, Keqin and Genovese, Mark C. (2011). Safety profile of subcutaneous abatacept focusing on clinically relevant events in patients with rheumatoid arthritis (RA) and up to 4.5 years of exposure. In: Abstracts of the American College of Rheumatology and Association of Rheumatology Health Professionals Annual Scientific Meeting. 75th Annual Scientific Meeting of the American College of Rheumatology/46th Annual Scientific Meeting of the Association of Rheumatology Health Professionals, Chicago, IL, United States, (S150-S151). 4-9 November 2011. doi:10.1002/art.33310 78   10 0
Mease, Philip, McInnes, Iain B., Kirkham, Bruce, Kavanaugh, Arthur, Rahman, Proton, van der Heijde, Desiree, Landewe, Robert, Nash, Peter, Pricop, Luminita, Yuan, Jiacheng, Richards, Hanno and Mpofu, Shephard (2014). Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study.. In: Arthritis & Rheumatology. , , (S423-S424). . 28   0
Gottlieb, Alice B., Mease, Philip, McInnes, Iain B., Kirkham, Bruce, Kavanaugh, Arthur, Rahman, Proton, Nash, Peter, Pricop, Luminita, Yuan, Jiacheng, Richards, Hanno and Mpofu, Shephard (2014). Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Significantly Reduces Psoriasis Burden in Patients with Psoriatic Arthritis: Results from a Phase 3 Randomized Controlled Trial. In: Arthritis & Rheumatology. , , (S233-S233). . 38   0
Sorrentino, Dario, Nash, Peter, Viladomiu, Monica, Hontecillas, Raquel and Bassaganya-Riera, Josep (2014) Stopping anti-TNF agents in patients with crohn's disease in remission: is it a feasible long-term strategy?. Inflammatory Bowel Diseases, 20 4: 757-766. doi:10.1097/01.MIB.0000442680.47427.bf 29   0 Cited 0 times in Scopus0 5
Genovese, Mark C., Cobos, Arturo, Leon, Gustavo, Mysler, Eduardo F., Keiserman, Mauro W., Valente, Robert M., Nash, Peter T., Campos, J. Abraham Simon, Porawska, Wiewlsawa, Box, Jane H., Legerton, Clarence W., Nasonov, Evgeny L., Durez, Patrick, Pappu, Ramesh, Delaet, Ingrid, Teng, Julie and Alten, Rieke (2012). Subcutaneous abatacept versus intravenous abatacept in patients with rheumatoid arthritis: Long-term data from the acquire trial. In: Rheumatology 2012 Abstracts: Poster Viewing II. Annual Meeting of the British-Society-for-Rheumatology, Glasgow, Scotland, (128-129). 1 - 3 May 2012. doi:10.1093/rheumatology/kes109 60   0 1
Genovese, Mark C., Cobos, Arturo Covarrubias, Leon, Gustavo, Mysler, Eduardo F., Keiserman, Mauro W., Valente, Robert M., Nash, Peter T., Campos, J. Abraham Simon, Porawska, Wieslawa, Box, Jane H., Legerton, Clarence W., Nasonov, Evgeny L., Durez, Patrick, Pappu, Ramesh, Delaet, Ingrid, Teng, Julie and Alten, Rieke (2011). Subcutaneous (SC) Abatacept (ABA) Versus Intravenous (IV) ABA in Patients (pts) with Rheumatoid Arthritis: Long-Term Data From the ACQUIRE (Abatacept Comparison of Sub[QU]cutaneous versus Intravenous in Inadequate Responders to MethotrexatE) Trial.. In: Abstracts of the American College of Rheumatology and Association of Rheumatology Health Professionals Annual Scientific Meeting. 75th Annual Scientific Meeting of the American College of Rheumatology/46th Annual Scientific Meeting of the Association of Rheumatology Health Professionals, Chicago, IL, United States, (S150-S150). 4-9 November 2011. doi:10.1002/art.33310 217   3 0
Denton, Christopher P., Avouac, Jerome, Behrens, Frank, Furst, Daniel E., Foeldvari, Ivan, Humbert, Marc, Huscher, Doerte, Kowal-Bielecka, Otylia, Matucci-Cerinic, Marco, Nash, Peter, Opitz, Christian F., Pittrow, David, Rubin, Lewis J., Seibold, James R. and Distler, Oliver (2011) Systemic sclerosis-associated pulmonary hypertension: Why disease-specific composite endpoints are needed. Arthritis Research and Therapy, 13 3: . doi:10.1186/ar3346 43   2 Cited 3 times in Scopus3 0
Helliwell, Philip S., FitzGerald, Oliver, Fransen, Jaap, Gladman, Dafna D., Kreuger, Gerald G., Callis-Duffin, Kristina, McHugh, Neil, Mease, Philip J., Strand, Vibeke, Waxman, Robin, Azevedo, Valderilio Feijo, Ostos, Adriana Beltran, Carneiro, Sueli, Cauli, Alberto, Espinoza, Luis R., Flynn, John A., Hassan, Nada, Healy, Paul, Kerzberg, Eduardo Mario, Lee, Yun Jong, Lubrano, Ennio, Marchesoni, Antonio, Marzo-Ortega, Helena, Porru, Giovanni, Moreta, Elvia G., Nash, Peter, Raffayova, Helena, Ranza, Roberto, Raychaudhuri, Siba P, Roussou, Euthalia, Scarpa, Raphael, Song, Yeong Wook, Soriano, Enrique R, Tak, Enrique R., Ujfalussy, Ilona, de Vlam, Kurt and Walsh, Jessica A. (2012) The development of candidate composite disease activity and responder indices for psoriatic arthritis. Annals of the Rheumatic Diseases, 72 6: 986-991. doi:10.1136/annrheumdis-2012-201341 87   27 Cited 26 times in Scopus26 0
Strange, Geoff and Nash, Peter (2009) The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy. International Journal of Rheumatic Diseases, 12 3: 192-206. doi:10.1111/j.1756-185X.2009.01410.x 13   Cited 4 times in Scopus4 0
Vanags, Daina, Williams, Bronwyn, Johnson, Barbara, Hall, Stephen, Nash, Peter, Taylor, Andrew, Weiss, Julissa and Feeney, Dennis (2006) Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: A double-blind randomised trial. The Lancet, 368 9538: 855-863. doi:10.1016/S0140-6736(06)69210-6 123   80 Cited 88 times in Scopus88 1
Nash, Peter (2006) Therapies for axial disease in psoriatic arthritis. A systematic review. Journal of Rheumatology, 33 7: 1431-1434. 114   30 Cited 44 times in Scopus44
van der Heijde, Désirée, Tanaka, Yoshiya, Fleischmann, Roy, Keystone, Edward, Kremer, Joel, Zerbini, Cristiano, Cardiel, Mario H., Cohen, Stanley, Nash, Peter, Song, Yeong-Wook, Tegzova, Dana, Wyman, Bradley T., Gruben, David, Benda, Birgitta, Wallenstein, Gene, Krishnaswami, Sriram, Zwillich, Samuel H., Bradley, John D., Connell, Carol A. and ORAL Scan Investigators (2013) Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study. Arthritis and Rheumatism, 65 3: 559-570. doi:10.1002/art.37816 76   47 Cited 54 times in Scopus54 30
van Vollenhoven, Ronald F., Fleischmann, Roy, Cohen, Stanley, Lee, Eun Bong, Garcia Meijide, Juan A., Wagner, Sylke, Forejtova, Sarka, Zwillich, Samuel H., Gruben, David, Koncz, Tamas, Wallenstein, Gene V., Krishnaswami, Sriram, Bradley, John D., Wilkinson, Bethanie, ORAL Standard Investigators and Nash, Peter T. (2012) Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. New England Journal of Medicine, 367 6: 508-519. doi:10.1056/NEJMoa1112072 85 3 118 Cited 142 times in Scopus142 40
Baker, Christopher, Mack, Alexandra, Cooper, Alan, Fischer, Gayle, Shumack, Stephen, Sidhu, Shireen, Soyer, Peter, Wu, Jason, Chan, Jonathan, Nash, Peter, Rawlin, Morton, Radulski, Barbara and Foley, Peter (2013) Treatment goals for moderate to severe psoriasis: An Australian consensus. Australasian Journal of Dermatology, 54 2: 148-154. doi:10.1111/ajd.12014 34   6 Cited 5 times in Scopus5 4
Nash, Peter T. and Florin, Timothy H. J. (2005) Tumour necrosis factor inhibitors. Medical Journal of Australia, 183 4: 205-208. 53   60 Cited 78 times in Scopus78
Nash, Peter, Lubrano, Ennio, Cauli, Alberto, Taylor, William J., Olivieri, Ignazio and Gladman, Dafna D. (2014) Updated guidelines for the management of axial disease in psoriatic arthritis. Journal of Rheumatology, 41 11: 2286-2289. doi:10.3899/jrheum.140877 17   1 Cited 1 times in Scopus1 0
Zochling, Jane, Nash, Peter, Riordan, John and Sambrook, Philip N. (2006) Use of corticosteroids and bone-active medications in clinical practice ane ZOCHLING1, Peter NASH2, John RIORDAN3, Philip N. SAMBROOK4. APLAR Journal of Rheumatology, 9 1: 37-42. doi:10.1111/j.1479-8077.2006.00162.x 35   Cited 2 times in Scopus2 0

Page 1 of 2

Result Pages:    1 2  next › last »